Picture of Zhaoke Ophthalmology logo

6622 — Zhaoke Ophthalmology News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Brief: Zhaoke Ophthalmology Says NMPA Acceptance Of New Drug Application For NVK002

Jan 2 (Reuters) - Zhaoke Ophthalmology Ltd  6622.HK :
    * NMPA ACCEPTANCE OF ABBREVIATED NEW DRUG- APPLICATION FOR
NVK002
FOR TREATMENT OF- MYOPIA PROGRESSION IN CHILDREN

Further company coverage:  6622.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zhaoke Ophthalmology

See all news